Scientific Publications Database

Article Title: The minimally effective dose of sucrose for procedural pain relief in neonates: a randomized controlled trial
Authors: Stevens, Bonnie; Yamada, Janet; Campbell-Yeo, Marsha; Gibbins, Sharyn; Harrison, Denise; Dionne, Kimberley; Taddio, Anna; McNair, Carol; Willan, Andrew; Ballantyne, Marilyn; Widger, Kimberley; Sidani, Souraya; Estabrooks, Carole; Synnes, Anne; Squires, Janet; Victor, Charles; Riahi, Shirine
Journal: BMC PEDIATRICS Volume 18
Date of Publication:2018
Abstract:
Background: Orally administered sucrose is effective and safe in reducing pain intensity during single, tissue-damaging procedures in neonates, and is commonly recommended in neonatal pain guidelines. However, there is wide variability in sucrose doses examined in research, and more than a 20-fold variation across neonatal care settings. The aim of this study was to determine the minimally effective dose of 24% sucrose for reducing pain in hospitalized neonates undergoing a single skin-breaking heel lance procedure.Methods: A total of 245 neonates from 4 Canadian tertiary neonatal intensive care units (NICUs), born between 24 and 42 weeks gestational age (GA), were prospectively randomized to receive one of three doses of 24% sucrose, plus non-nutritive sucking/pacifier, 2 min before a routine heel lance: 0.1 ml (Group 1; n = 81), 0.5 ml (Group 2; n = 81), or 1.0 ml (Group 3; n = 83). The primary outcome was pain intensity measured at 30 and 60 s following the heel lance, using the Premature Infant Pain Profile-Revised (PIPP-R). The secondary outcome was the incidence of adverse events. Analysis of covariance models, adjusting for GA and study site examined between group differences in pain intensity across intervention groups.Results: There was no difference in mean pain intensity PIPP-R scores between treatment groups at 30 s (P =.97) and 60 s (P =.93); however, pain was not fully eliminated during the heel lance procedure. There were 5 reported adverse events among 5/245 (2.0%) neonates, with no significant differences in the proportion of events by sucrose dose (P =.62). All events resolved spontaneously without medical intervention.Conclusions: The minimally effective dose of 24% sucrose required to treat pain associated with a single heel lance in neonates was 0.1 ml. Further evaluation regarding the sustained effectiveness of this dose in reducing pain intensity in neonates for repeated painful procedures is warranted.